Table 2.
Comparison between genetic modification using lentiviral or retroviral vectors and gene editing.
Retroviral/lentiviral vectors |
Gene editing |
||
---|---|---|---|
Advantages | Disadvantages | Advantages | Disadvantages |
High transduction efficiency and easy transduction procedures | Random integration into the genome | Endogenous regulation of transgenic TCRs/CARs. In CARs-T cells, endogenous regulation avoids overexpression, tonic signaling and T-cell exhaustion | Lower modification efficiency |
Easy manufacturing on small scale | Variable transgene expression | Homogeneous expression | Off-target double-stranded breaks |
Artificial regulation from viral vector promoter can lead to transgene silencing or overexpression | Knock-in and knock-out can be multiplexed. Potential to increase T cell potency and generate off-the-shelf T-cell products | Electroporation, Cas9, and HDR donor-induced toxicity. Decreased T-cell expansion | |
Costly and time-consuming large-scale manufacturing at GMP/clinical grade | Viral and non-viral methods. The non-viral methods allow for fast reagent manufacturing at GMP/clinical level | ||
No TCR mispairing | |||
Lower cost with non-viral methods |
CAR, chimeric antigen receptor; GMP, good manufacturing practices; HDR, homology-directed repair; TCR, T-cell receptor.